Cargando…
Desiccated Thyroid Extract Versus Synthetic LT4/T3 Combination Versus LT4 Monotherapy in the Treatment of Primary Hypothyroidism With Special Attention to the Thr92AlaD2 Polymorphism. With Special Attention to the Gene Polymorphism
Introduction: Before the availability of levothyroxine (LT4), patients were treated with desiccated thyroid extract (DTE). When switching from DTE to LT4, despite adequate dosing based on serum TSH levels, some patients still feel unwell with fatigue, mental fogginess, weight gain etc. A recent rand...
Autores principales: | Hoang, Thanh Duc, Brooks, Daniel I, Bianco, Antonio, Mcaninch, Elizabeth A, Fonseca, Tatiana L, Mai, Vinh Q, Shakir, Mohamed K M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090032/ http://dx.doi.org/10.1210/jendso/bvab048.1687 |
Ejemplares similares
-
Whole-Genome Shotgun Sequences of Salmonella enterica Serovar Typhimurium Lilleengen Type Strains LT1, LT18, LT19, LT20, LT21, and LT22
por: Kazmierczak, Robert A., et al.
Publicado: (2017) -
Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design
por: Premawardhana, Lakdasa D., et al.
Publicado: (2023) -
Improvement of depression in a patient with hypothyroidism and deiodinase polymorphism with LT3 Therapy
por: Ahmed, Ziyan S., et al.
Publicado: (2022) -
Age Worsens the Cognitive Phenotype in Mice Carrying the Thr92Ala-DIO2 Polymorphism
por: Lorena, Fernanda B., et al.
Publicado: (2022) -
Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function
por: DiStefano, Joseph, et al.
Publicado: (2019)